Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
07/01/2009 | CN101468042A Pharmaceutical formulation for treating osteoarthropathy and method for preparing the same |
07/01/2009 | CN101468041A Method for inactivating hereditary substance of fish sperm using X ray and use thereof |
07/01/2009 | CN101468040A Ear pyogenesis powder and formulating method thereof |
07/01/2009 | CN101468039A Method for preparing compound double-layer sustained-release medicinal membrane for treating oral mucosal disease |
07/01/2009 | CN101468038A Microecological oral liquid for treating gastropathy |
07/01/2009 | CN100506844C Novel peptides |
07/01/2009 | CN100506281C Method and device for feeding living cells into a biological body fluid |
07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
07/01/2009 | CN100506236C Method for preparing liposome of pearl digest |
06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
06/30/2009 | US7555153 Non-invasive joint evaluation |
06/30/2009 | US7553935 Modified vitamin K-dependent polypeptides |
06/30/2009 | US7553934 Enhanced membrane binding affinity; blood coagulation |
06/30/2009 | US7553870 Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events |
06/30/2009 | US7553664 Methods for cultivating dermal fibroblasts, methods for preparing in vitro dermis equivalents, methods for preparing three-dimensional in vitro skin equivalents, an in vitro dermis equivalent, a three dimensional in vitro skin |
06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
06/30/2009 | US7553613 Coagulation, mechanical agitation; filtration |
06/30/2009 | CA2368812C Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy |
06/30/2009 | CA2143486C Method of improving the immune response |
06/25/2009 | WO2009078799A1 New vaccine for the treatment of mycobacterium related disorders |
06/25/2009 | WO2009078348A1 Method of producing liquid earthworm extract and method of producing dry earthworm powder |
06/25/2009 | WO2009077749A1 Formulations comprising exine shells |
06/25/2009 | WO2009077352A1 Prevention of opportunistic infections in immune-compromised subjects |
06/25/2009 | WO2009076778A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
06/25/2009 | WO2009057975A3 Pharmaceutical composition for the prevention and treatment of cell proliferative diseases comprising of the feathers of birds as the active ingredient |
06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
06/25/2009 | US20090162934 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
06/25/2009 | US20090162452 EB Matrix Production From Animal Tissue And Its Use For Tissue Repair |
06/25/2009 | US20090162445 bone repair; containing demineralized bone fragments and homogenized connective tissues; used in many different forms |
06/25/2009 | US20090162433 Method of treatment |
06/25/2009 | US20090162419 Live bacteria product |
06/25/2009 | US20090162411 Encapsulated kidney tissue |
06/25/2009 | US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
06/25/2009 | US20090162389 Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity |
06/25/2009 | US20090162386 Chondrocyte therapeutic delivery system |
06/25/2009 | US20090162376 Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
06/25/2009 | US20090162374 Specific removal of activated immune cells |
06/25/2009 | US20090162351 Transdiscal administration of inhibitors of p38 MAP kinase |
06/25/2009 | US20090162344 Method for Fermentation and Culture, Fermented Plant Extract, Fermented Plant Extract Composition, Method for Producing Lipopolysaccharide and Lipopolysaccharide |
06/25/2009 | US20090162334 Production and use of regulatory t cells |
06/25/2009 | US20090162333 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases |
06/25/2009 | US20090162332 Methods and compositions for treating brain diseases |
06/25/2009 | US20090162331 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
06/25/2009 | US20090162330 Method of Isolating Human Neuroepithelial Precursor Cells from Human Fetal Tissue |
06/25/2009 | US20090162329 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
06/25/2009 | US20090162328 In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation |
06/25/2009 | US20090162327 Bone marrow transplantation for treatment of stroke |
06/25/2009 | US20090162325 Cell implantation to prevent and/or treat autoimmune disease |
06/25/2009 | US20090162324 Use of Whole Cell Actinomycetales Bacteria to Treat Stress-Induced Pulmonary Haemorrhage |
06/25/2009 | US20090162322 Oral administration form comprising probiotic bacteria |
06/25/2009 | US20090162321 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
06/25/2009 | US20090162317 Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same |
06/25/2009 | US20090162304 Compositions and methods for treating skin conditions in mammals |
06/25/2009 | US20090162288 Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods |
06/25/2009 | CA2709396A1 Prevention of opportunistic infections in immune-compromised subjects |
06/25/2009 | CA2708443A1 Formulations comprising exine shells |
06/25/2009 | CA2707235A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
06/24/2009 | EP2072053A1 Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
06/24/2009 | EP2072052A1 Prevention of opportunistic infections in immune-compromised subjects |
06/24/2009 | EP1643846A4 Method for treatment of sores and lesions of the skin |
06/24/2009 | EP1579865A4 Means for preventing and curing endocrine system disturbances |
06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
06/24/2009 | EP1372398A4 Rapid preparation of stem cell matrices for use in tissue and organ treatement and repair |
06/24/2009 | EP1131106B1 Compositions and methods for producing vascular occlusion |
06/24/2009 | CN101461827A Total saponins in Holothuria nobilis Selenka with anti-tumor function |
06/24/2009 | CN101461826A Method for industrial production of bezoar by chemical method |
06/24/2009 | CN100503814C Methods of preparing a transplantable product for treatment of skin defects |
06/24/2009 | CN100502893C Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
06/24/2009 | CN100502892C Chewing tablet of Rana chensinensis, and preparation method |
06/24/2009 | CN100502891C Use of gekko powder for preparing medicine for treating colon adenocarcinoma |
06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
06/24/2009 | CN100502671C Method for manufacturing hydroxyethyl glycosaminoglycan film-forming agent for fresh-keeping of winter jujube |
06/24/2009 | CN100502670C Method for manufacturing carboxymethyl glycosaminoglycan film-forming agent for fresh-keeping of winter jujube |
06/23/2009 | US7550285 Endotoxin binding lactic acid bacteria and bifidobacteria |
06/23/2009 | US7550283 Bacteriophage for lysis of Methylobacterium and compositions and uses thereof |
06/23/2009 | US7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
06/23/2009 | US7550139 Megasphaera elsdenii strain and its uses |
06/23/2009 | CA2337494C Herpes virus vectors for dendritic cells |
06/23/2009 | CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
06/21/2009 | CA2647175A1 Process for grafting a porous element for leukodepletion |
06/18/2009 | WO2009076548A1 Methods of inhibiting tumor development using adipose-derived regenerative cells |
06/18/2009 | WO2009076455A2 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
06/18/2009 | WO2009076317A2 Activated t cells |
06/18/2009 | WO2009075556A1 Method for sensitising cells and the use of same for treating tumours |
06/18/2009 | WO2009074754A1 Use of a bifidobacterium strain for preparing a composition for preventing and/or treating allergic manifestations |
06/18/2009 | WO2009073931A1 Nutraceutical composition and methods of use |
06/18/2009 | WO2009073930A1 Nutraceutical composition and methods of use |
06/18/2009 | WO2009073905A2 Method for increasing immunoreactivity |
06/18/2009 | WO2009058451A3 Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells |
06/18/2009 | WO2009045356A8 Microrna compositions in the treatment of vegf-mediated disorders |
06/18/2009 | US20090157017 Bioresorbable foaming tissue dressing |
06/18/2009 | US20090156689 Method of enhancing biological activity of plant extracts |
06/18/2009 | US20090155378 Osteoinductive demineralized cancellous bone |
06/18/2009 | US20090155377 plant extracts for prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders; side effects reduction |
06/18/2009 | US20090155376 Protein hydrolysate with antidiabetic effect |
06/18/2009 | US20090155340 Method of cell storage in a delivery system |
06/18/2009 | US20090155332 Replacement bone tissue |
06/18/2009 | US20090155304 Modified Cyanovirin-N Polypeptide |
06/18/2009 | US20090155301 Pseudoinfectious flavivirus and uses thereof |